Number of Shares
1,097.00
Current Holdings Value*
$267,800.00
% of Portfolio
3.93%
Total Estimate Gain
$784.94
% of Total Estimate Gain
0.11%

Baillie Gifford Health Innovation Equities Fund's ResMed Inc Holding Summary

As of 2024-09-30, Baillie Gifford Health Innovation Equities Fund held 1,097.00 shares of ResMed Inc(RMD), totaling $267,800.00. This investment constitutes 3.93% of their stock portfolio, and Baillie Gifford Health Innovation Equities Fund now holds 0% of the outstanding ResMed Inc(RMD) stock.

The initial trade took place in 2022Q1. And since then Baillie Gifford Health Innovation Equities Fund has made 6 purchases of RMD, at an average price of $220.95, for a total of 3,310.00 shares. In addition, there have been 3 sales at an average price of $202.98 for 2,213.00 shares. Based on historical transaction data and RMD's current price of $257.92, Baillie Gifford Health Innovation Equities Fund's estimated gain on his RMD holdings is $784.94, reflecting a 0.11% gain to date.

Baillie Gifford Health Innovation Equities Fund RMD ($257.92) Holding Chart

Baillie Gifford Health Innovation Equities Fund RMD ($257.92) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1